Corrective Phases R...
Health Care: Health Services
Baxter International Inc. (BAX: NYSE)
$50.06 -0.11 | -0.22%
06/04/12 - 04:01 PM ET
Latest Dividend:0.34
Latest Dividend Yield:2.58%
Dividend Ex-Date:06/06/12
Price Earnings Ratio:12.85
Price Earnings Comparisons:
| BAX | Sector Avg. | S&P 500 |
|---|---|---|
| 12.85 | 12.80 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| -13.95 | -14.53 | 1.91 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 8.20 | 0.13 | 0.04 |
| Net Income | 56.60 | 0.10 | 0.03 |
| EPS | 62.30 | 0.21 | 0.07 |
Earnings for BAX:
| EBITDA | 3.62B |
| REVENUE | 13.89B |
Average Earnings Estimates
| Qtr (06/12) | Qtr (09/12) | FY (12/12) | FY (12/13) | |
|---|---|---|---|---|
| Average Estimate | $1.11 | $1.17 | $4.54 | $4.93 |
| Number of Analysts | 15 | 15 | 18 | 17 |
| High Estimate | $1.13 | $1.19 | $4.65 | $5.06 |
| Low Estimate | $1.09 | $1.15 | $4.49 | $4.75 |
| Prior Year | $1.07 | $1.09 | $4.31 | $4.54 |
| Growth Rate (Year over Year) | 3.99% | 6.97% | 5.39% | 8.61% |
Portfolios with BAX
- Portfolio NameUser Type
- ProJohn Paulson
- ContributorMost-Searched Stocks for th...
- ContributorTop-Yielding Health Service...
- ProBill Frels - Mairs & Power
- ProHighbridge Capital Management
- ProFarallon Capital Management
- UserDividend Income 2011-11-23
- ProJohn Buckingham - Al Frank ...
- ContributorDividend Stocks for the Wee...
- Contributor9 Stocks With Low Volatilit...
Latest BAX Headlines from TheStreet
- Baxter International Inc. (BAX): Today's Featured Health Services Loser 05.25.12 | 05:05 pm
- 6 Low-Yield Dividend Captures 05.18.12 | 11:05 am
- Baxter International Inc. (BAX): Today's Featured Health Services Loser 05.11.12 | 04:05 pm
- 'Mad Money' Lightning Round: Devon's Worth More 04.19.12 | 07:04 pm
- Baxter International's CEO Discusses Q1 2012 Results - Earnings Call Transcript 04.19.12 | 02:04 pm
- NYSE Stocks Posting Largest Percentage Decreases 04.16.12 | 06:04 pm
- Mattel, Endocyte, Ivanhoe Are Market Movers 04.16.12 | 05:04 pm
- 7 Hot Stocks on Traders' Radars 04.16.12 | 03:04 pm
- NYSE Stocks Posting Largest Percentage Decreases 04.16.12 | 01:04 pm
- 'Mad Money' Lightning Round: Bullish on Baxter 03.27.12 | 07:03 pm
Press Releases for BAX
- Baxter Announces Collaboration With Chatham Therapeutics For Factor IX Hemophilia B Gene Therapy Treatment - Business Wire 06.04.12 | 09:06 am
- Baxter To Present At William Blair & Company 32nd Annual Growth Stock Conference - Business Wire 05.30.12 | 04:05 pm
- Baxter’s Low Glucose PD Solutions Favorably Impacted Metabolic Measures Including Glycemic Control In Trials Of Diabetics Undergoing Dialysis - Business Wire 05.25.12 | 03:05 am
- Baxter To Present At Goldman Sachs 33rd Annual Global Healthcare Conference - Business Wire 05.23.12 | 04:05 pm
- Baxter Announces ADVATE Approval In China For The Treatment Of Hemophilia A - Business Wire 05.16.12 | 09:05 am
- Baxter Declares Quarterly Dividend - Business Wire 05.07.12 | 04:05 pm
- Baxter To Present At Bank Of America Merrill Lynch 2012 Healthcare Conference - Business Wire 05.02.12 | 04:05 pm
- Leading Health Economist Mark V. Pauly, Ph.D., Named 2012 Recipient Of The Willam B. Graham Prize For Health Services Research - Business Wire 05.01.12 | 09:05 am
- Baxter Completes Purchase Of Sigma International - Business Wire 04.26.12 | 08:04 am
- Baxter To Present At Deutsche Bank Securities, Inc. 37th Annual Healthcare Conference - Business Wire 04.24.12 | 04:04 pm
Partner Headlines for BAX
- Baxter And Neostem Validating Each Other's Cell Therapies - Seeking Alpha 06.01.12 | 09:06 am
- Stock Analysts Upgraded or Downgraded These Shares on Jun 1st - Wall St. Cheat Sheet 06.01.12 | 04:06 am
- UPDATE: Citi Lowers Baxter's PT - Benzinga 04.20.12 | 09:04 am
- Notable Options Activity in BAX - Benzinga 04.16.12 | 01:04 pm
- Baxter International Inc.: Worth A Look - Seeking Alpha 03.12.12 | 09:03 am
- Haemonetics Reaffirmed at Neutral - Analyst Blog - Zacks 03.02.12 | 06:03 pm
- Boston Scientific Offers Investors Huge Valuation Upside - Seeking Alpha 02.29.12 | 09:02 am
- Significant Upside Of About 25% For Baxter, Covidien - Seeking Alpha 02.24.12 | 05:02 pm
- Mylan Looks To Reap A Harvest Of Patent Expirations - Seeking Alpha 02.22.12 | 09:02 am
- Building A Capital Preservation And Income Portfolio, Part 8 - Seeking Alpha 02.17.12 | 04:02 pm
